3 results
The primary objectives of this study are: * To characterize the effects of 150 mg and 450 mg of AT1001 administered 2 hours before administration of agalsidase on the safety and plasma pharmacokinetics of agalsidase in subjects with Fabry Disease*…
Investigate the incidence and severity of early coagulopathy in severe sepsis and septic shock patients and investigate the correlation between these coagulation disturbances and the incidence and severity of microvascular changes.
Primary Objective: Does induced hypothermia using NovathermTM combined with the iLA-Activve MinilungTm result in a reduction in minute volume ventilation and work of breathing by reducing positive peak inspiratory pressure levels in patients with…